Showing results (951-960 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|November 19, 2022
The relevance of social and commercial determinants for neurological healthSebastian Walsh, Richard Merrick, Carol Brayne
The Lancet. Neurology|February 22, 2025
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort studyAnita van de Munckhof, Mayte Sánchez van Kammen, Turgut Tatlisumak, et al.
The Lancet. Neurology|January 25, 2025
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled studyCarlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
The Lancet. Neurology|January 25, 2025
Crossing the blood-brain barrier: emerging therapeutic strategies for neurological diseaseJosephine H Pedder, Adam M Sonabend, Michael D Cearns, et al.
The Lancet. Neurology|November 22, 2024
Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case seriesGerard Mayà, Alex Iranzo, Carles Gaig, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
The Lancet. Neurology|March 22, 2025
Epilepsy with myoclonic-atonic seizures: an update on genetic causes, nosological limits, and treatment strategiesRenzo Guerrini, Ingrid Scheffer, Simona Balestrini
The Lancet. Neurology|October 24, 2024
Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinicShen-Yang Lim, Ai Huey Tan, Azlina Ahmad-Annuar, et al.
The Lancet. Neurology|October 18, 2024
Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trialTiffany J Braley, Dawn M Ehde, Kevin N Alschuler, et al.
Pageof 200